Resources

ASCO 2019: Top Data and Developments

Home | Resources

Research Objectives:

  • Capture areas of greatest excitement regarding data presented or developments that took place during the American Society of Clinical Oncology (ASCO) Annual Meeting, June 2019 in Chicago.

Methodology:
Method: MicroSurvey via InCrowd
Crowds: Oncologists and Hematology-Oncologists
Sample Size: n=80 physicians, each providing 3 separate mentions for a total of 240 unique data points
Fielding Period: 2 days immediately following conference close
Screening Criteria: Qualified respondents are US-based oncs and hem/oncs who: Attended the ASCO Annual Meeting held between May 31 – June 4, 2019 in Chicago, IL in person

One key finding:

  • ASCO 2019 attendees most commonly cited developments in Lung, Breast, and Prostate cancers as exciting developments at this year’s conference.

Download the full report now!

Please fill out the form below to access this content

Name(Required)
Consent
This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more